Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0033687 (proteinuria)
 24,015 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

To investigate the effects of LMWH on proliferative nephritis, we randomized 41 patients who had obvious mesangial cell proliferation testified by renal biopsy into 2 groups according to age, course, clinical manifestations and the pathological lesions. The patients in the control group were given steroid, cyclophosphamide and bennazipril, and the patients in the treated group LMWH (fraxiparin) with the dosage of 60 anti Xa IU.kg-1.day-1 besides the medicine used in the control group. We observed a significant decrease in proteinuria and increase in serum albumin in the treated group compared with those in the control group after 4 weeks of treatment (P < 0.05). The improvement of creatinine clearance in the treated group was significant after 8 and 12 weeks treatment compared with that in the control group (P < 0.05). Our data indicated that LMWH can decrease the proteinuria in the patients who have intraglomerular coagulation and proliferative nephritis with various degrees of sclerosis, and it is helpful to relieve nephrotic syndrome. Because the less risk of hemorrhage, LMWH can be used for long-term treatment to prevent glomerulosclerosis and the process of renal function loss without special mornitoring.
Zhonghua Nei Ke Za Zhi 1997 Nov
PMID:[Effects of low-molecular-weight heparin on proliferative glomerulonephritis]. 1045 43

To disclose the prevalence of thin membrane nephropathy (TMN) in China and its clinical and pathological features, we prospectively studied TMN cases including 722 cases of renal biopsies in 2 years. 27 cases (male 7 cases, female 20) were diagnosed as primary glomerulonephritis. The GBM thicknesses of TMN group (n = 27) and control group (n = 32) was 207 +/- 36 nm and 382 +/- 34 nm (P < 0.01) respectively. IF of TMN was negative or trace, near normal morphology or mild mesangial proliferative glomerulo nephritis was observed by LM. A few of them had global glomerular sclerosis or single crescent formation. All TMN patients had microscopic hematuria. About one third (9/27 cases) patients with TMN presented isolated persistent microscopic hemataria, 44.4% (12/27 cases) and 22.2% (6/27 cases) patients with TMN were accompanied with mildmoderate proteinuria and heavy proteinuria (> or = 3.5 g/24 h) or nephrotic syndrome. The patients with heavy proteinuria or nephrotic syndrome had good response to corticosteroid therapy. All patients with TMN had normal renal function, only a few of them had transient hypertension. The results showed that the prognosis of TMN would be regarded as good. The familial history of 15 patients with TMN was investigated, and 47% (7/15 cases) of them had > or = two members with microscopic hematuria in their families. TMN was found in 3.7% (27/722 cases) in total renal biopsies and 11.5% (9/78 cases) in the patients with isolated microscopic hematuria. It suggests that TMN isn't a rare kidney disease in China. Careful EM is a critical method for the correct diagnosis of TMN.
Zhonghua Nei Ke Za Zhi 1997 Nov
PMID:[Thin membrane nephropathy: 27 cases]. 1045 44

OBJECTIVE To investigate the effects of angiotensin-converting enzyme inhibitor (ACEI) on IgA nephropathy(IgAN) and the factors influencing the therapeutic effects. METHODS 131 cases with IgAN diagnosed by renal biopsy were randomly divided into two groups: ACEI group (benazepril 10 mg/d) and non-ACEI group as control. The pathological changes in the kidney were analyzed using Lee SMK. RESULTS After 1 month treatment of ACEI, the levels of proteinuria and serum cholesterol decreased significantly, meanwhile those of serum albumin and total protein increased obviously in patients with IgAN(P < 0.05). The proteinuria level at the 3rd month after treatment was lower than that at the 1st month, but was same as that at the 18th month. While in the control group the proteinuria level increased and the clearance of creatinine decreased continuously during the observation (P < 0.05). The effects correlated positively with mesangial proliferation and negatively with course of the disease glomerular sclerosis in glomerulus and changes of small arterioles in the kidney. Normal blood pressare normal renal function I approximately II degree of Lee SMK I degee of interstitial changes minimal changes of small arterioles and mild glomerular sclerosis predicted better response to ACEI treatment than hypertension renal insufficiency V degree of Lee SMK IV degee of interstitial changes severe changes of small arterioles and massive glomerular sclerosis. CONCLUSIONS It is suggested that benezepril could definitely reduce the excretion of urinary protein and protect renal function of patients with IgAN and should be used as earlier as possible. Mesangial prolife ration glomerular sclerosis in glomerulus changes of small arterioles in kidney and course of the disease are the major influencing factors of ACEI treatment on IgAN.
Zhonghua Nei Ke Za Zhi 2002 Jun
PMID:[The effects of angiotensin-converting enzyme inhibitor on IgA nephropathy and the influencing factors]. 1213 3

Nephrotic syndrome (NS) is a renal disease characterized by heavy proteinuria, hypoalbuminemia, edema and hyperlipidemia. Its presentation within the first 3 months of life or in multiple family members suggests an underlying inherited cause. To determine the frequency of inherited NS, 62 cases (representing 49 families with NS) from Saudi Arabia were screened for mutations in NPHS1, NPHS2, LAMB2, PLCE1, CD2AP, MYO1E, WT1, PTPRO and Nei endonuclease VIII-like 1 (NEIL1). We detected likely causative mutations in 25 out of 49 families studied (51%). We found that the most common genetic cause of NS in our cohort was a homozygous mutation in the NPHS2 gene, found in 11 of the 49 families (22%). Mutations in the NPHS1 and PLCE1 genes allowed a molecular genetic diagnosis in 12% and 8% of families, respectively. We detected novel MYO1E mutations in three families (6%). No mutations were found in WT1, PTPRO or NEIL1. The pathogenicity of novel variants was analyzed by in silico tests and by genetic screening of ethnically matched control populations. This is the first report describing the molecular genetics of NS in the Arabian Peninsula.
...
PMID:A molecular genetic analysis of childhood nephrotic syndrome in a cohort of Saudi Arabian families. 2359 23


<< Previous 1 2 3